Search
Fraunhofer Institute for Toxicology and Experimental Medicine
Fraunhofer Institute for Toxicology and Experimental Medicine
Events
Press and media
Career
Contact
Deutsch
Institute
[X]
Institute
Contact persons
Organizational structure
Institute directors
Quality assurance
Our network
Institute chronicles
Board of trustees
Mission statement
R&D expertise
[X]
R&D expertise
Cardiopulmonary research
Toxicology
Immunology and infection research
Malignant disease research
Medical and Pharmaceutical Engineering
Bioinformatics and AI
RNA technologies
Services
[X]
Services
Drug Development
GMP manufacturing of biopharmaceuticals for clinical trials
Regulatory research and risk assessment in drug development
Preclinical research and testing
Efficacy
Toxicology testing
Clinical trials
Chemical safety and assessment
Bio- and Environmental Analytics
Toxicology testing
Exposure characterization
Regulatory risk assessment
Regulatory research
Translational Biomedical Engineering
Device development and manufacturing processes
Testing and test methods
Regulatory support
Personalized Tumor Therapy
Single-cell analytics
Enrichment, isolation and molecular analysis of rare cells
Decoding single cells
Innovative tumor models
In-vitro and in-vivo drug testing
Advanced preclinical PDX models
Mathematical modeling and bioinformatics
Multi-level disease modeling
Bioinformatics services and consulting
CRC Hannover
Events
[X]
Events
Science Campus@Home 2021
23rd DGRA Annual Congress
ERS International Congress 2021
5th ACTC 2021: Advances in Circulating Tumor Cells
BioEM – The Joint Annual Meeting of the Bioelectromagnetics Society and the European BioElectromagnetics Association
Oral presentation at New and Emerging Technologies 2021
DGK Herztage
Congress of the European Society of Gene and Cell Therapy
2nd International Akademie Fresenius Conference
Models of Lung Disease 2022 - Save the date
Oral presentation within the LifeScienceNet Düsseldorf webinar
Oral presentation at OECT Summit 2022
7th German Pharm-Tox Summit
SOT Annual Meeting and ToxExpo 2022 in San Diego
Regulatory Forum
3R in cardiovascular research
Fraunhofer CIMD Summer School 2022
AACR 2022
Development of predictive human stem cell-based models in neurotoxicology and -infectiology
ATS 2022
CIMD session 3: NGRA
ENDS Europe 2022
ONE – Health, Environment, Society – Conference 2022
LIVe2022
EACR 2022 annual congress
CIMD session 4: In vitro tissue models
CIMD session 5: Multiplex immunohistology
10th IWPFI – Lung Imaging Together in Hannover
CIMD session 6: Human immunocompetent lung model for infection studies
CIMD session 7: In silico methods in regulatory toxicology – skin sensitization as an example
Models of Lung Disease 2023 - Save the date
Workshop "Alternatives to Animal Testing" 2023 - Save the date
SOT Annual Meeting and ToxExpo 2023 in Nashville
8th German Pharm-Tox Summit
Models of Lung Disease 2023
Program
ATS 2023
KSOT 2023
ENDS 2023
Inhaled Particles and NanOEH Conference 2023
Alternatives to Animal Testing 2023
Press and media
[X]
Press and media
Newsletter
Annual reports
Publications
Press releases
Reviewing OECD Test Guidelines
Rhinovirus-induced human lung tissue responses mimic COPD and asthma gene signatures
ZeroPM: Zero pollution from persistent, mobile substances
AVATOR - Tracking down aerosols
AVATOR - Indoor Air: How to Eliminate Viruses Effectively
ATMPs – long way to clinical application, but high therapeutic added value
Institute director Prof. Thomas Thum is one of the most cited researchers worldwide
Understanding heart failure and developing innovative therapies
Rapid therapeutic approaches for viral diseases
Machine learning in pediatric intensive-care medicine
REMEDIA project
Project MONO4ERA
Alternative to animal models: Advances in medicine through human-relevant disease models
Better models to shed light on the mutagenicity of N-nitrosamines
COVID-19 Research Network Lower Saxony: Pooling expertise to fight SARS-CoV-2
RNA therapy for heart failure and organ fibrosis
Inhaling microplastics – how dangerous is that?
Clinical trial MVA: Researchers want to test the efficacy of an inhaled vaccine
Checking the immune response in the lungs
Natural product-based compound screening identifies highly efficient anti-fibrotic substances
Fraunhofer heading for future predictive models
Prof. Ulrich Mohr passed away
On the home stretch to the RNA drug against cardiac fibrosis
Automated production technologies for mRNA-based drugs
Fraunhofer project FibroPaths®: enabling rapid and safe development of antifibrotic drugs
Novel immune cell platforms for health research – start of Fraunhofer Attract group in Hannover
Multi-organ chip detects dangerous nanoparticles
Project Biosynth
1.5 million euros for rapid therapies against viral diseases
High Performance Center at COMPAMED 2022
Designer immune cells for drug discovery, potency and safety testing
Bioresorbable membrane for healing internal and external wounds
News
Thematic Flyers
Career
[X]
Career
Direct entry
Students
Contact
More
Where am I?
English
Services
Personalized Tumor Therapy
Innovative tumor models
Innovative tumor models
In-vitro and in-vivo drug testing
read more
Advanced preclinical PDX models
read more
Fraunhofer Institute for Toxicology and Experimental Medicine